Mobiles Menu Mobiles Menu Close

Adjusted EBT

The Adjusted EBITDA Total for continuing operations amounted to € 1,266.5 million in the first six months of 2024 and was thus 2.6% lower than the prior-year value of € 1,299.8 million in the first six months of 2023. 

In the 2024 reporting period, the non-recurring items eliminated in the Adjusted EBT came to € 45.4 million (6M 2023: € 119.2 million). The following table gives a detailed list of the non-recurring items:

Non-recurring Items

Non-recurring Items

in € million

H1 2023

H1 2024

Change in %

12M 2023

Transactions*

82.9

12.9

-84.4

70.0

Personnel matters

26.6

14.7

-44.7

35.1

Business model optimization

6.2

14.4

>100

34.9

Research & development

3.4

2.9

-14.7

6.8

Refinancing and equity measures

0.1

0.5

>100

1.1

Total non-recurring items

119.2

45.4

-61.9

147.9

  1. *Including one-time expenses in connection with acquisitions, such as HR measures relating to the integration process and other follow-up costs.